1. Home
  2. RAIL vs CGTX Comparison

RAIL vs CGTX Comparison

Compare RAIL & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAIL
  • CGTX
  • Stock Information
  • Founded
  • RAIL 1901
  • CGTX 2007
  • Country
  • RAIL United States
  • CGTX United States
  • Employees
  • RAIL N/A
  • CGTX N/A
  • Industry
  • RAIL Railroads
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RAIL Industrials
  • CGTX Health Care
  • Exchange
  • RAIL Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • RAIL 186.1M
  • CGTX 158.8M
  • IPO Year
  • RAIL N/A
  • CGTX 2021
  • Fundamental
  • Price
  • RAIL $8.48
  • CGTX $1.66
  • Analyst Decision
  • RAIL
  • CGTX Strong Buy
  • Analyst Count
  • RAIL 0
  • CGTX 3
  • Target Price
  • RAIL N/A
  • CGTX $2.83
  • AVG Volume (30 Days)
  • RAIL 130.1K
  • CGTX 1.3M
  • Earning Date
  • RAIL 11-10-2025
  • CGTX 11-06-2025
  • Dividend Yield
  • RAIL N/A
  • CGTX N/A
  • EPS Growth
  • RAIL N/A
  • CGTX N/A
  • EPS
  • RAIL N/A
  • CGTX N/A
  • Revenue
  • RAIL $465,864,000.00
  • CGTX N/A
  • Revenue This Year
  • RAIL $2.94
  • CGTX N/A
  • Revenue Next Year
  • RAIL $6.92
  • CGTX N/A
  • P/E Ratio
  • RAIL N/A
  • CGTX N/A
  • Revenue Growth
  • RAIL N/A
  • CGTX N/A
  • 52 Week Low
  • RAIL $4.31
  • CGTX $0.22
  • 52 Week High
  • RAIL $16.10
  • CGTX $3.83
  • Technical
  • Relative Strength Index (RSI)
  • RAIL 39.28
  • CGTX 48.96
  • Support Level
  • RAIL $8.17
  • CGTX $1.54
  • Resistance Level
  • RAIL $8.81
  • CGTX $1.77
  • Average True Range (ATR)
  • RAIL 0.47
  • CGTX 0.13
  • MACD
  • RAIL -0.13
  • CGTX -0.01
  • Stochastic Oscillator
  • RAIL 17.91
  • CGTX 31.49

About RAIL FreightCar America Inc.

FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. The company has two segments: The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and rebuilds, while the Aftermarket segment includes the selling of forged, cast and fabricated railcar parts and supplies for all railcar types, and provides aftermarket services including safety training, railcar inspections, and preventative maintenance. The company's revenue is predominantly derived from its Manufacturing segment.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: